AKT Health

What AKT Health does

AKT Health is a private healthcare and life sciences strategy consulting firm founded in 2017, operating across Tokyo (Japan), Hyderabad (India), Boston (United States), and Basel (Switzerland). The company serves biopharmaceutical, medical device, and healthcare system clients with an integrated approach that connects clinical, medical, commercial, and outcomes research workflows traditionally handled in functional silos.

The firm's core technology is the Impakt Platform Suite, an AI-powered healthcare analytics ecosystem comprising seven specialized modules: Datakapt (electronic data capture with GDPR, HIPAA, and 21 CFR Part 11 compliance), Pulse (real-time trial monitoring with predictive enrollment analytics), AI-Driven Dashboards, Impakt Medical (KOL identification and scientific content via NLP), Impakt Commz (omnichannel engagement), Impakt Outcomes (health economics and real-world evidence), Impakt Health (Software as a Medical Device for decentralized clinical trials and remote patient monitoring), and Impakt Life (medical devices for continuous monitoring). The platform is built on an API-first architecture intended to enable seamless data flow across modules. Recent additions include the HAIOps governance framework for healthcare AI (May 2026) and a pharmaceutical-grade data annotation service (April 2026).

AKT Health generates revenue through subscription-based licensing of the Impakt platform suite, professional services across clinical, medical, commercial, and outcomes domains, and specialized data annotation services. The company runs an enterprise field-sales motion with quote-based pricing indicated by 'Request a Demo' CTAs, targeting a horizontal segmentation strategy across biopharma, medical devices, and healthcare systems. Distribution is augmented by a channel partnership with Certara covering Japan, India, Sri Lanka, Bangladesh, and Pakistan. Leadership consists of CEO Rashmi Gurnani and President Aditya Tallapragada.

Name

AKT Health

Legal name

AKT Health Analytics

Website

https://akthealth.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

AKT Health is a private healthcare and life sciences strategy consulting firm that sells the Impakt Platform Suite — an integrated AI-powered analytics ecosystem — alongside consulting and data annotation services to biopharmaceutical, medical device, and healthcare system clients across Asia-Pacific, North America, Europe, and the Middle East.

Ownership category

akta.pro rank

Product category

Healthcare Analytics Software

NAICS

Software Publishers (513210), Computer Systems Design Services (541512), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Healthcare analytics consulting
• Clinical trial analytics platform
• Health economics outcomes research
• Medical affairs solutions
• AI healthcare intelligence

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare Analytics Platform Licensing: Enterprise licensing of the Impakt Platform Suite including Clinical Suite, Medical, Commz, Outcomes, Health, and Life modules. Delivered as integrated SaaS platform with subscription-based pricing for biopharmaceutical, medical device, and healthcare system clients.
2. Professional Services: Consulting services spanning Clinical, Medical, Commercial, and Outcomes research. Expert-guided solutions for strategic planning, technology implementation, and regulatory compliance across the asset lifecycle.
3. Data Annotation Services: Pharmaceutical-grade data annotation services for healthcare and life sciences AI training. Specialized annotation process for model accuracy in healthcare AI applications.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

AKT Health delivers an AI-powered healthcare analytics platform called the Impakt Suite, integrating clinical trial management, medical affairs, commercial strategy, and health economics & outcomes research for biopharmaceutical, medical device, and healthcare system clients. The firm combines this proprietary software with expert consulting, data annotation, and a regulatory-grade governance framework (HAIOps) to help life sciences organizations accelerate drug development, improve data quality, and demonstrate value across global markets.

Product overview

AKT Health offers the Impakt Platform, a unified AI-powered healthcare analytics ecosystem comprising six specialized modules: Impakt Clinical Suite (containing Datakapt, Pulse, and AI Driven Dashboards), Impakt Medical, Impakt Commz, Impakt Outcomes, Impakt Health (SaMD), and Impakt Life (medical devices). These integrated platforms work together to transform healthcare data into actionable insights across clinical trial optimization, medical affairs, commercial strategy, and outcomes research, powered by 90% reduction in paper processes, 80% improvement in data quality, and 65% efficiency in management.

Differentiator

Problem solved

Functional benefit

Brands

• Impakt: AI-Powered Healthcare Analytics Platform - the complete product ecosystem that transforms healthcare data into actionable insights across clinical, medical, commercial, and outcomes domains.
• Impakt Health
• Impakt Life
• Datakapt
• Pulse
• Impakt Medical
• Commz
• Impakt Outcomes
• HAIOps

Products and services

• Impakt Platform Suite The Impakt Platform Suite is an AI-powered healthcare analytics ecosystem that integrates clinical trial management, medical affairs, commercial strategy, and health economics & outcomes research workflows for biopharmaceutical, medical device, and healthcare system clients across clinical, medical, commercial, and outcomes domains.
• Healthcare Strategy Consulting Services Expert consulting services across Clinical, Medical, Commercial, and Outcomes research spanning protocol optimization, evidence generation, stakeholder alignment, market access, HEOR modeling, and biotech growth support for biopharmaceutical, medical device, and healthcare system clients.
• HAIOps Framework A regulatory-grade governance framework for Healthcare AI that delivers AI-powered insights, analytics, and intelligence capabilities to support healthcare governance, compliance, safety, and clinical accountability.
• Pharmaceutical-Grade Data Annotation Service A pharmaceutical-grade data annotation service for the healthcare and life sciences industries, providing specialized annotation processes to improve model accuracy and reliability in healthcare AI applications.

Quantifiable outcome

• 90% reduction in paper processes
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• DiaGen AIcoreStrategic or Co-development Partner · 13 March 2026Strategic partnership established through appointment of AKT Health President Aditya Tallapragada to DiaGen AI Advisory Board. DiaGen AI is a Vancouver-based tech-bio company developing generative AI tools for small molecule and peptide drug discovery. The collaboration enables DiaGen to leverage AKT Health's established global networks across Asia-Pacific, Middle East, and North America, while AKT Health gains access to DiaGen's generative AI platform for molecular discovery. The partnership reflects the broader industry shift toward enterprise-scale deployment of generative AI tools in active drug pipelines, positioning both organizations at the convergence of computational biology and clinical development.
• CertaracoreChannel Partner/ Reseller/ DistributorAKT Health Analytics serves as an authorized distribution and promotional partner for Certara, a global leader in biosimulation software and technology. The partnership covers Phoenix, Pinnacle21, D360, and SEND Explorer distribution and support across Japan, India, Sri Lanka, Bangladesh, and Pakistan. AKT Health provides 100% authorized partnership with official distribution and promotional rights, 24/7 regional support with local expertise across time zones. This collaboration enhances model-informed drug development and streamlines regulatory processes to improve patient outcomes.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Medidata (Dassault Systèmes): Industry-standard EDC, CTMS, eCOA, and decentralized clinical trial platform; directly competes with AKT's Datakapt and Pulse modules within the same enterprise pharma buying centers.
• Trinity Life Sciences: Strategy consulting firm combining evidence generation, HEOR, medical affairs, and commercial analytics with proprietary technology for biopharma; overlaps with AKT's consulting-plus-platform model.
• Veeva Systems: Cloud platform serving clinical, regulatory, medical, and commercial functions across life sciences; the most direct software peer to AKT's Impakt suite, with greater scale and broader product depth.
• Evidera (Thermo Fisher / PPD): HEOR, real-world evidence, and value demonstration provider for biopharma; directly comparable to AKT's Impakt Outcomes module in payer landscape, budget impact modeling, and value communication.
• Saama Technologies: AI-driven clinical analytics and data management platform for life sciences; closely comparable to AKT's Datakapt, Pulse, and AI Dashboard components in clinical trial operations.
• Indegene: Hybrid consulting-and-technology provider for biopharma spanning Medical Affairs, Commercial, and HEOR with proprietary platforms; closely comparable to AKT Health's integrated, AI-powered life sciences model.

Broad incumbents

• ICON plc: Global CRO with clinical, consulting, and technology capabilities including decentralized trials; overlaps with AKT across clinical development services and DCT support.
• ZS Associates: Management consulting firm with deep analytics and technology capabilities for pharma commercial strategy and market access; overlaps with AKT's Commz and Outcomes offerings at large enterprise accounts.
• Certara: Biosimulation and regulatory science software leader (Phoenix, Pinnacle21, D360, SEND Explorer); both a distribution partner and an indirect competitor in model-informed drug development and regulatory workflows.
• IQVIA: Largest CRO and life sciences analytics incumbent offering clinical, HEOR, commercial, and technology services; competes broadly across multiple Impakt modules and customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/akthealth

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AKT Health